Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dienogest vs GnRH agonist after laparoscopic surgery for endometriosis
IRCT20091012002576N25Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dienogest in endometriosis (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Pelvic pain reduction and Pregnancy outcome. Started Apr 2022; status: completed.
02
Drugs
dienogest
03
Conditions
endometriosis
Beyond the preview
Go deeper on IRCT20091012002576N25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20091012002576N25.